8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The SecuritiesExchange Act of 1934

Date of Report (Date of earliest event reported)

January 30, 2024

HEALTHCARE TRIANGLE, INC.

(Exact name of registrant as specified in its charter)

(925)-270-4812

**(**Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.02 Termination of a Material Definitive Agreement.

On January 30, 2024, Devcool, Inc. (the “Supplier”), a wholly-owned subsidiary of the Healthcare Triangle, Inc. (“HCTI” or the “Company”) received a letter from Guidant Global Inc. (“Guidant”), terminating the Supplier Master Services Agreement (the “Agreement”) by and between Guidant and the Supplier, regarding the Supplier’s services to City of Hope National Medical Center, City of Hope Medical Foundations, Beckman Research Institute of the City of Hope, and City of Hope effective February 04, 2024.

The Company is currently assessing the materiality of the termination of the Agreement and the impact of the potential termination. A copy of the termination letter is filed with this report as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

2

Exhibit 99.1

January 30, 2024

Devcool Inc

5890 Stoneridge Dr #107

Pleasanton, CA 94588

RE: Termination of Staffing Company Agreement between Guidant Global, Inc. and Devcool Inc

Dear Supplier:

The purpose of this letter is to provide Devcool Inc (“Supplier”) with notice of Guidant Global Inc.’s (“Guidant”) termination of the Supplier Master Services Agreement entered into between Guidant and Supplier on August 10, 2021 (as amended, the “Agreement”) regarding Supplier’s provision of contingent workers to City of Hope National Medical Center, City of Hope Medical Foundations, Beckman Research Institute of the City of Hope, and City of Hope.

Guidant is terminating the Agreement for its convenience pursuant to Section 1.2.2 of the Agreement. Supplier will receive no new business effective immediately. Supplier must satisfy any and all continuing obligations under the Agreement that survive termination.

Guidant Global will be scheduling a call to discuss options for your active worker population and partner together to minimize disruption to City of Hope. Termination of the contractual relationship will be effective February 04, 2024, to allow for the agreed upon transition of workers. Should all workers’ assignments end before such date, the Agreement will terminate as of that date.

We wish Supplier success in its future endeavours. If you have any questions or concerns, please contact Katrina James at katrina.james@guidantglobal.com.